Delivery Order SPE2DB22D2005-SPE2DB25FJKU0
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Pediarix 0.5 ML syringes, a pediatric vaccine, with a ceiling value of $3,642.88 and a period of performance through May 9, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Pediarix 0.5 ML syringes, a vaccine product, with a ceiling value of $2,166.15 and a period of performance through April 17, 2025. The contract is a firm-fixed-price delivery order, which is non-set-aside, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,945.56, is for the supply of 4,567,926,364 units of the pediatric vaccine Pediarix in 0.5 mL syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pediarix 0.5 ML syringes, a pediatric vaccine product. The contract has a firm fixed price, a ceiling value of $3,938.64, and a period of performance through April 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pediarix 0.5 ML Syringes, a pediatric vaccine product. The contract has a ceiling value of $4,253.00 and is a firm fixed-price delivery order type contract. The period of performance runs through May 27, 2025. This award is not a set-aside contract, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,463.00, is for the delivery of Pediarix 0.5 ML syringes, a pediatric combination vaccine. The contract is a Firm Fixed Price (FFP) delivery order, with an ultimate completion date of April 16, 2025. The contract is not set-aside and was open to full and open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pediarix 0.5 ML Syringe 0.5ML, a pediatric vaccine, with a ceiling value of $7,781.80 and a performance period through April 30, 2025. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $1,658.40 firm fixed-price contract is for the supply of Pediarix 0.5 ML syringes, a pediatric vaccine. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded various federal contracts to provide a wide range of medical products, including specialty medications, drugs, vaccines,...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine. The award has a Firm Fixed Price of $10,168.56 and a completion date of December 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,299.69, is for the delivery of 4,568,060,953 units of the vaccine Pediarix 0.5 ML Syringe. The contract is a firm fixed-price, non-set-aside award with a performance period through April 29, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJKU0Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Pediarix 0.5 ML Syringe 0.5ML, a pediatric vaccine product. The award is not set aside and has a ceiling value of $21,892.31. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.9k | 4/7/25 |